title: Use of tissue plasminogen activator to resolve high purge system pressure in a catheter-based ventricular-assist device.
authors.affiliation: Department of Clinical Engineering, University of Maryland Medical Center, Baltimore, Maryland.
authors.forename: Erik N
authors.initials: EN
authors.lastname: Sorensen
authors.affiliation: Department of Pharmacy, University of Maryland Medical Center, Baltimore, Maryland.
authors.forename: Pharmd
authors.initials: P
authors.lastname: Carla Williams
authors.affiliation: Department of Medicine, University of Maryland Medical Center, Baltimore, Maryland.
authors.forename: Ali
authors.initials: A
authors.lastname: Tabatabai
mesh_terms: D001783:Blood Flow Velocity / Q000187:drug effects* / Q000502:physiology*; D001794:Blood Pressure / Q000187:drug effects* / Q000502:physiology*; D020878:Device Removal; D019544:Equipment Failure Analysis; D006353:Heart-Assist Devices; D006801:Humans; D008297:Male; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D011183:Postoperative Complications / Q000188:drug therapy* / Q000503:physiopathology*; D011474:Prosthesis Design; D011475:Prosthesis Failure; D016459:Prosthesis-Related Infections / Q000601:surgery*; D012086:Reoperation; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D010959:Tissue Plasminogen Activator